Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance
January 27, 2011 - … a prior district court ruling invalidating the patent for Strattera ® . The company is currently awaiting the appeals … 1,030.4 (1)% Forteo ® 226.3 212.8 6% 830.1 816.7 2% Strattera 155.4 162.2 (4)% 576.7 609.4 (5)% Animal Health … increased demand, and to a lesser extent, higher prices. Strattera During the fourth quarter of 2010, Strattera …
Lilly Caps Successful Year with Strong Fourth-Quarter Results
January 29, 2008 - … Alimta(R), Byetta(R), Cialis(R), Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and Yentreve(R) -- … 42% 854.0 611.8 40% Forteo 198.2 172.1 15% 709.3 594.3 19% Strattera 156.8 156.3 0% 569.4 579.0 (2)% Total Sales - … driven by increased demand and favorable exchange rates. Strattera During the fourth quarter of 2007, Strattera …
Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges
January 26, 2006 - … Alimta(R), Byetta(R), Cialis(R), Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and Yentreve(R) -- … 1,012.7 2% Cymbalta 228.8 61.3 N/M* 679.7 93.9 N/M* Strattera 168.0 183.4 (8%) 552.1 666.7 (17%) Alimta 135.8 … compared with third quarter 2005 sales of $182.8 million. Strattera During the fourth quarter of 2005, Strattera, the …
Lilly Reports Results for Second Quarter; Sales Increase 3 Percent
July 21, 2005 - … (non-joint-venture sales), Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and Yentreve(R) -- … (5%) 510.5 509.4 0% Cymbalta 161.4 - N/M* 268.2 - N/M Strattera 123.5 178.6 (31%) 243.2 319.7 (24%) Alimta 111.2 … additional launches expected throughout 2005 and 2006. Strattera --------- During the second quarter of 2005, …
Lilly Announces Third-Quarter Earnings Per Share of $.69; Company Also Details Restructuring Activities
October 21, 2004 - … products - Alimta ® , Cialis ® , Cymbalta ® , Forteo ® , Strattera ® , Symbyax ™, Xigris ® and Yentreve ® - … products - Alimta ® , Cialis ® , Cymbalta ® , Forteo ® , Strattera ® , Symbyax ™, Xigris ® and Yentreve ® - … products - Alimta ® , Cialis ® , Cymbalta ® , Forteo ® , Strattera ® , Symbyax ™, Xigris ® and Yentreve ® - …
Lilly Reports Fourth-Quarter and Full-Year 2012 Results, Revises 2013 EPS Guidance
January 29, 2013 - … 949.8 21% Evista ® 241.0 267.1 (10)% 1,010.1 1,066.9 (5)% Strattera ® 163.9 170.6 (4)% 621.4 620.1 0% Effient ® 120.6 … extent, the unfavorable impact of foreign exchange rates. Strattera During the fourth quarter of 2012, Strattera generated $163.9 million of sales, a decrease of 4 …
Lilly Reports Solid First-Quarter Results
April 21, 2008 - … Alimta(R), Byetta(R), Cialis(R), Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and Yentreve(R) -- … 225.8 14 % Alimta 247.2 187.8 32 % Forteo 185.0 153.4 21 % Strattera 148.0 139.9 6 % Total Sales - Reported $4,807.6 … demand and the favorable impact of foreign exchange rates. Strattera During the first quarter of 2008, Strattera …
Lilly Reports First-Quarter 2013 Results
April 24, 2013 - … (49)% Forteo ® 281.5 271.3 4% Evista ® 240.6 256.2 (6)% Strattera ® 166.7 158.9 5% Effient ® 115.9 115.8 0% Animal … impact of foreign exchange rates and lower prices. Strattera During the first quarter of 2013, Strattera generated $166.7 million of sales, an increase of 5 …
Lilly Reports Third-Quarter 2010 Results
October 21, 2010 - … of New Jersey ruled that the method-of-use patent for Strattera(R) is invalid. The patent had been set to expire in … 7% Evista 256.8 259.5 (1)% Forteo(R) 199.7 213.1 (6)% Strattera 127.9 145.5 (12)% Animal Health 353.2 314.6 12% … 7% Evista 757.9 767.7 (1)% Forteo(R) 603.8 603.9 (0)% Strattera 421.3 447.2 (6)% Animal Health 967.0 854.0 13% …
Lilly Reports Fourth-Quarter and Full-Year 2008 Results
January 29, 2009 - … Alimta(R), Byetta(R), Cialis(R), Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and Yentreve(R) -- … 1,063.2 985.2 8% Forteo 194.5 198.2 (2)% 778.7 709.3 10% Strattera 146.8 156.8 (6)% 579.5 569.4 2% Total Sales -- … extent the favorable impact of foreign exchange rates. Strattera During the fourth quarter of 2008, Strattera …